Reprogramming anchorage dependency to develop cell lines for recombinant protein expression.

Area of Science:

• Biotechnology
• Cell Biology
• Biopharmaceutical Manufacturing

Background:

• Biopharmaceutical production relies on cell lines capable of anchorage-independent growth for large-scale manufacturing.
• Inducing suspension adaptations and efficient transfection in cell lines remains a significant challenge.
• Developing novel human cell lines is crucial for enhancing biopharmaceutical production efficiency.

Purpose of the Study:

• To identify factors that enable adherent cells to grow independently of attachment.
• To develop an inducible and reversible system for reprogramming cell anchorage dependency.
• To improve transfection efficiency and protein expression rates in biomanufacturing cell lines.

Main Methods:

• Identification of "Adherent-to-Suspension Transition" (AST) factors: IKZF1, BTG2, and KLF1.
• Establishment of 293-AST cells and 293-AST-TetR cells from the HEK293A cell line.
• Development of an inducible and reversible reprogramming system for anchorage dependency.

Main Results:

• The identified AST factors successfully induced anchorage-independent growth in adherent cells.
• The AST-TetR system demonstrated inducible and reversible reprogramming of anchorage dependency.
• The AST-TetR system significantly increased transfection efficiency and protein expression rates.

Conclusions:

• The AST-TetR system provides a novel technological platform for developing advanced cell lines.
• This system facilitates more efficient biopharmaceutical production by overcoming challenges in cell adaptation and transfection.
• The findings pave the way for improved cell line development in the biopharmaceutical industry.